Quadcap Wealth Management’s AbbVie ABBV Stock Holding History

Quadcap Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.21M	Buy	12,770 +804	+7%	+$173K	0.31%	68
2026 Q1	$2.6M	Sell	11,966 -45	-0.4%	-$9.98K	0.3%	75
2025 Q4	$2.74M	Sell	12,011 -33	-0.3%	-$7.52K	0.31%	69
2025 Q3	$2.79M	Sell	12,044 -21	-0.2%	-$4.28K	0.33%	67
2025 Q2	$2.24M	Sell	12,065 -102	-0.8%	-$19K	0.28%	69
2025 Q1	$2.55M	Buy	12,167 +154	+1%	+$29.9K	0.37%	58
2024 Q4	$2.13M	Sell	12,013 -376	-3%	-$69.1K	0.31%	65
2024 Q3	$2.45M	Buy	12,389 +1,357	+12%	+$253K	0.38%	55
2024 Q2	$1.89M	Buy	11,032 +436	+4%	+$72.2K	0.34%	63
2024 Q1	$1.93M	Sell	10,596 -354	-3%	-$61K	0.44%	49
2023 Q4	$1.7M	Buy	+10,950	New	+$1.6M	0.44%	57

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Quadcap Wealth Management's ABBV Position: Q2 2026 in Review

Quadcap Wealth Management increased its AbbVie (ABBV) stake by 6.7% in Q2 2026, buying an estimated $173K and bringing the position to 12,770 shares worth $3.21M. The position accounts for 0.31% of the portfolio, ranked #68.

Quadcap Wealth Management first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Quadcap Wealth Management held 12,770 shares of AbbVie worth $3.21M as of Q2 2026.
Quadcap Wealth Management bought 804 AbbVie shares in Q2 2026, an estimated $173K.
AbbVie made up 0.31% of Quadcap Wealth Management's portfolio in Q2 2026, its #68 holding.
Quadcap Wealth Management first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Quadcap Wealth Management's 13F filing for Q2 2026, filed 31 Jul 2026.